RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Piletz to Depression

This is a "connection" page, showing publications John Piletz has written about Depression.
Connection Strength

0.268
  1. Ma JK, Zhu HE, Piletz JE. Effect of postmortem delay on imidazoline receptor-binding proteins in human and mouse brain. Ann N Y Acad Sci. 2003 Dec; 1009:341-6.
    View in: PubMed
    Score: 0.146
  2. Piletz JE, Schubert DS, Halaris A. Evaluation of studies on platelet alpha 2 adrenoreceptors in depressive illness. Life Sci. 1986 Nov 03; 39(18):1589-616.
    View in: PubMed
    Score: 0.045
  3. Halaris A, Piletz JE. Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress. Ann N Y Acad Sci. 2003 Dec; 1009:1-20.
    View in: PubMed
    Score: 0.036
  4. Zhu H, Paul IA, McNamara M, Redmond A, Nowak G, Piletz JE. Chronic imipramine treatment upregulates IR2-imidazoline receptive sites in rat brain. Neurochem Int. 1997 Jan; 30(1):101-7.
    View in: PubMed
    Score: 0.023
  5. Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry. 1993 Nov 15; 34(10):676-86.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support